Internal Medicine · New York, NY
NPI
1487640900
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
8 Chatham Sq, Suite 206
New York, NY, 10038
Phone (212) 732-6992
Medicare paid, 2024
$82K
1,638 services
Medicare patients, 2024
156
Average age 82
Drug cost, 2024
$3.3M
29,535 prescriptions
Company payments, 2025
$105
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ching-Yin Lam was code 99213 (office e&m - established), 655 times for 151 patients. In total Ching-Yin Lam billed 1,638 services in 24 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 655 | 151 | $63.88 | $42K |
| 36415 Venipuncture Blood Collection | Office | 222 | 136 | $2.94 | $653 |
| 82962 Clinical Chemistry | Office | 131 | 65 | $3.21 | $421 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 117 | 117 | $144.22 | $17K |
| G0008 Administration of influenza virus vaccine | Office | 106 | 106 | $36.26 | $3,844 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 105 | 105 | $20.35 | $2,137 |
| 93000 Electrocardiogram | Office | 83 | 76 | $10.23 | $849 |
| 90662 Vaccine Product | Office | 68 | 68 | $81.82 | $5,564 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 45 | 29 | $32.30 | $1,454 |
| 99214 Office E&M - Established | Office | 34 | 25 | $77.40 | $2,632 |
| 90658 Vaccine Product | Office | 20 | 20 | $21.42 | $428 |
| 90653 Vaccine Product | Office | 14 | 14 | $58.80 | $823 |
By year: 2022 $94K for 2,058 services; 2023 $84K for 1,828 services; 2024 $82K for 1,638 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 222 | 136 | $2.94 | $653 |
| 82962 Clinical Chemistry | 131 | 65 | $3.21 | $421 |
Medicare prescription drug claims, 2024
In 2024, the drug Ching-Yin Lam prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,417 prescriptions and refills. In total Ching-Yin Lam wrote 29,535 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,417 | 2,650 | 254 | $9,609 |
| Amlodipine Besylate Generic | 1,186 | 2,019 | 223 | $5,168 |
| Atorvastatin Calcium Generic | 1,068 | 2,015 | 193 | $6,825 |
| Losartan Potassium Generic | 1,063 | 1,850 | 183 | $5,685 |
| Metoprolol Succinate Generic | 934 | 1,668 | 160 | $6,207 |
| Omeprazole Generic | 867 | 1,151 | 182 | $7,584 |
| Raloxifene Hcl Generic | 840 | 1,360 | 128 | $17K |
| Gabapentin Generic | 666 | 757 | 133 | $5,492 |
| Olmesartan Medoxomil Generic | 571 | 969 | 105 | $4,777 |
| Vascepa Icosapent Ethyl | 498 | 596 | 66 | $202K |
| Tamsulosin Hcl Generic | 453 | 787 | 91 | $3,442 |
| Finasteride Generic | 435 | 791 | 85 | $2,776 |
| Metformin Hcl Generic | 432 | 739 | 77 | $1,832 |
| Montelukast Sodium Generic | 429 | 619 | 90 | $2,276 |
| Farxiga Dapagliflozin Propanediol | 409 | 607 | 63 | $343K |
Brand drugs: 4,639 claims; generic drugs: 24,516 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ching-Yin Lam $105 ($105 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $54.7.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.